DEPRET, F., L. BOUTIN, Jiří JARKOVSKÝ, M. CHAUSSARD, S. SOUSSI, A. BATAILLE, H. OUESLATI, N. MORENO, C. de TYMOWSKI, Jiří PAŘENICA, Klára BENEŠOVÁ, T. VAUCHEL, A. FERRY, M. BENYAMINA, A. CUPACIU, M. COUTROT, J.P. GARNIER, K. SERROR, M. CHAOUAT, A. MEBAZAA and M. LEGRAND. Prediction of major adverse kidney events in critically ill burn patients. Burns. OXFORD: ELSEVIER SCI LTD, 2018, vol. 44, No 8, p. 1887-1894. ISSN 0305-4179. Available from: https://dx.doi.org/10.1016/j.burns.2018.08.007.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prediction of major adverse kidney events in critically ill burn patients
Authors DEPRET, F. (250 France), L. BOUTIN (250 France), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), M. CHAUSSARD (250 France), S. SOUSSI (250 France), A. BATAILLE (250 France), H. OUESLATI (250 France), N. MORENO (250 France), C. de TYMOWSKI (250 France), Jiří PAŘENICA (203 Czech Republic, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), T. VAUCHEL (250 France), A. FERRY (250 France), M. BENYAMINA (250 France), A. CUPACIU (250 France), M. COUTROT (250 France), J.P. GARNIER (250 France), K. SERROR (250 France), M. CHAOUAT (250 France), A. MEBAZAA (250 France) and M. LEGRAND (250 France, guarantor).
Edition Burns, OXFORD, ELSEVIER SCI LTD, 2018, 0305-4179.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.247
RIV identification code RIV/00216224:14110/18:00104900
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.burns.2018.08.007
UT WoS 000451331200004
Keywords in English Plasmatic Neutrophil Gelatinase-Associated Lipocain; Acute kidney injury; Burn patients; Major adverse kidney event
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 23/4/2024 10:05.
Abstract
Objective: We aimed at assessing the predictive value of plasmatic Neutrophil Gelatinase Associated Lipocalin (pNGAL) at admission and severity scores to predict major adverse kidney events (MAKE, defined as death and/or need for renal replacement therapy (RRT) and/or non-renal recovery at day 90) in critically ill burn patients. Material and methods: Single-center cohort study in a burn critical care unit in a tertiary center, including all consecutive severely burn patients (total burned body surface >20%) from January 2012 until January 2015 with a pNGAL dosage at admission. Reclassification of patients was assessed by Integrated Discrimination Improvement (IDI). Measurements and results: 87 patients were included. Mean age was 47.7 (IQ 25-75: 33.4-65.2) years; total burn body surface area was 40 (IQ 25-75: 30-55) % and ICU mortality 36%. 39(44.8%) patients presented a MAKE, 32(88.9%) patients died at day 90. pNGAL was higher in the MAKE group (423 [IQ25-75: 327-518] pg/mL vs 184 [IQ25-75: 147-220] pg/mL, p<0.001). In multivariate analysis, pNGAL and abbreviated burn severity index (ABSI) remained associated with MAKE (OR 1.005 [CI 95% 1.0005-1.009], p=0.03 and OR 1.682 [CI95%1.038-2.726], p=0.035 respectively). Adding pNGAL to abbreviated burn severity index, simplified organ failure assessment and the simplified acute physiology score 2 did outperform clinical scores for the prediction of MAKE and AKI and for most severe forms of AKI and allowed a statistically significant reclassification of patients compared to ABSI for MAKE, RRT, AKI at Day 7 and AKI during hospitalization with a number of patients needed to screen to detect one extra episode of MAKE was 44, 13 for severe AKI and 15 for AKI. Conclusions: pNGAL at admission is associated with the risk of MAKE in this population, and outperform severity scores when associated. Interventional studies are now needed to assess if impact of biomarkers-guided strategies would improve outcome. (C) 2018 Elsevier Ltd and ISBI. All rights reserved.
PrintDisplayed: 21/7/2024 17:20